Diffuse large B-cell lymphoma is the most common type of non-Hodgkin’s lymphoma, which may be associated with infection, genetics, immune abnormalities, etc. Patients can be treated with immunotherapy combined with chemotherapy in the CHOP regimen.
1. Immunotherapy: patients can use immunosuppressants such as rituximab to attack CD20 molecules on the surface of B cells, which is important for the treatment of diffuse large B-cell lymphoma.
2. CHOP regimen: CHOP regimen refers to the combination of cyclophosphamide + doxorubicin + vincristine + prednisone. Immunotherapy combined with CHOP regimen can significantly improve the effectiveness of the treatment of diffuse large B-cell lymphoma.
It is recommended that patients go to professional hospitals, actively cooperate with doctors, and choose the appropriate treatment plan under the guidance of doctors to avoid delaying the condition. All the drugs mentioned above should be used under the guidance of doctors.